M1713 TRANSIENT ELASTOGRAPHY Discloses Identical Distribution of Liver Fibrosis in Chronic Hepatitis C Between HIV-Negative and HIV-Positive Patients On HAART

Objective Progressive immunodeficiency associated with HIV-infection leads to a progressive course of liver disease in HIV/HCV-co-infected patients. Highly active antiretroviral therapy (HAART) efficiently restores and preserves immune functions and has recently been demonstrated to also result in reduced liver-related mortality in HIV/HCV-co-infected patients.